Food Research International, Journal Year: 2024, Volume and Issue: 197, P. 115157 - 115157
Published: Oct. 2, 2024
Language: Английский
Food Research International, Journal Year: 2024, Volume and Issue: 197, P. 115157 - 115157
Published: Oct. 2, 2024
Language: Английский
Eye, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 17, 2025
Language: Английский
Citations
0Experimental Eye Research, Journal Year: 2025, Volume and Issue: 254, P. 110304 - 110304
Published: Feb. 19, 2025
Language: Английский
Citations
0Experimental Eye Research, Journal Year: 2025, Volume and Issue: 254, P. 110303 - 110303
Published: Feb. 20, 2025
Language: Английский
Citations
0Antioxidants, Journal Year: 2025, Volume and Issue: 14(4), P. 492 - 492
Published: April 18, 2025
Advanced glycation end products (AGEs) are a group of compounds formed through non-enzymatic reactions between reducing sugars and proteins, lipids, or nucleic acids. AGEs can be generated in the body introduced dietary sources smoking. Recent clinical animal studies have highlighted significant role various health conditions. These accumulate nearly all mammalian tissues associated with range diseases, including diabetes its complications, cardiovascular disease, neurodegeneration. This review summarizes major diseases linked to AGE accumulation, presenting both experimental evidence. The pathologies induced by share common mechanisms across different organs, primarily involving oxidative stress, chronic inflammation, direct protein cross-linking. Interventions targeting AGE-related focus on inhibiting formation using synthetic natural antioxidants, as well intake lifestyle modifications. recognized risk factors that impact accelerate aging, particularly individuals hyperglycemia. Monitoring level implementing nutritional interventions help maintain overall reduce complications.
Language: Английский
Citations
0Investigative Ophthalmology & Visual Science, Journal Year: 2025, Volume and Issue: 66(4), P. 58 - 58
Published: April 21, 2025
To compare the impact of sodium-glucose cotransporter 2 (SGLT2) and dipeptidyl peptidase 4 (DPP-4) inhibitors on age-related macular degeneration (AMD) risk among patients with type diabetes mellitus (T2DM). This multinational, retrospective cohort study used electronic medical records from healthcare institutions across 21 countries. Adults 50 years or older T2DM who had a prior prescription metformin initiated SGLT2 DPP-4 2013 to 2023 were included. The inhibitor groups propensity score matched in 1:1 ratio balance baseline characteristics followed for up 5 observe occurrence AMD. Statistical analysis was performed using Cox proportional hazards model Kaplan-Meier analysis. Our final included 20,966 prescribed inhibitors. Compared group, group associated significantly lower risks AMD (hazard [HR], 0.71; 95% confidence interval [CI], 0.58-0.85) dry (HR, 0.61; CI, 0.46-0.80) but not wet 0.74; 0.48-1.16). compared linked reduced White population, empagliflozin dapagliflozin, individuals glycated hemoglobin < 8.5%, estimated glomerular filtration rate ≥ 60 mL/min/1.73 m2, hypertension, dyslipidemia, regardless body mass index level. In T2DM, those may experience
Language: Английский
Citations
0Food Research International, Journal Year: 2024, Volume and Issue: 197, P. 115157 - 115157
Published: Oct. 2, 2024
Language: Английский
Citations
0